211633-85-1Relevant academic research and scientific papers
USE OF DDX3 INHIBITORS AS ANTIPROLIFERATIVE AGENTS
-
Page/Page column 79; 80, (2017/10/30)
The present invention refers to compounds of formula I or II endowed with DDX3 inhibitory activity, relative pharmaceutical compositions and their use as antihyperproliferative agents. (I) or (II)
HUMAN HELICASE DDX3 INHIBITORS AS THERAPEUTIC AGENTS
-
Page/Page column 86; 87, (2016/09/22)
The present invention refers to compounds endowed with RNA helicase DDX3 inhibitory activity of formula I and II and their therapeutic use, in particular for the treatment of viral diseases.
Applied Technique of 1,3-Dipolar Cycloaddition to Synthesis of New Fluoroquinolones
Nagibina,Sidorova,Klyuev,Charushin,Chupakhin
, p. 1468 - 1475 (2007/10/03)
A new synthetic approach to modification of 4-oxo-6-fluoro-1,4-dihydroquinoline-3-carboxylic acids based on applications of technique of 1,3-dipolar cycloaddition is suggested. Fluoroquinolines bearing typical 1,3-dipolar azido or azomethineoxide groups a
